Cargando…

PMU82 Increasing Importance of Digital CME in a Post COVID-19 World

Detalles Bibliográficos
Autores principales:	Eslami, N., Infante, K., Harris, B., Erickson, G., Hoyvald, C., Garfield, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2020
Materias:	Multiple Diseases - Organizational Practices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732217/ http://dx.doi.org/10.1016/j.jval.2020.08.1294

Ejemplares similares

PMU5 The Future of Market Access in a Post COVID-19 World - What Do WE Need to Do Differently?
por: Teale, C., et al.
Publicado: (2020)

PMU1 Evolving Access Under COVID-19
por: Cook, J.
Publicado: (2021)

PMU7 Efficiency-Based Protocols for BEDS Evacuation during the COVID-19 Pandemic
por: Nepomuceno, T., et al.
Publicado: (2020)

PMU12 How Are Quarantine Impacting on the Health-Related Quality of Life?
por: Ramos-Goñi, J.M., et al.
Publicado: (2020)

PMU58 Americans' Health Priorities during the COVID-19 Pandemic
por: Cook, J., et al.
Publicado: (2021)

PMU3 Mortality from General Surgical Procedures: A Comparison of the Pre-Versus Peri-COVID Era
por: Elangovanraaj, N., et al.
Publicado: (2020)

PMU85 IMPACT of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe
por: Halioua, B., et al.
Publicado: (2020)

The Psychiatry Milestones 2.0: How Did We Get from 1.0 to 2.0 and What Can Users Expect?
por: Macaluso, Matthew, et al.
Publicado: (2020)

The Psychological Space of Professionals’ Trust and Distrust in Socio-Technical Systems
por: Akimova, Anna Yu., et al.
Publicado: (2022)

Working Remotely During the COVID-19 Pandemic: Work-Related Psychosocial Factors, Work Satisfaction, and Job Performance Among Russian Employees
por: Toscano, Ferdinando, et al.
Publicado: (2022)

Counterproductive Work Behavior in Russian Nanotechnology Organizations
por: Sayapina, Karina, et al.
Publicado: (2021)

Psychological Burnout among Professionals Working with Children with Motor Disabilities
por: Al-Ali, Taghreed, et al.
Publicado: (2021)

PNS86 How US Clinical Trials Are Being Reimagined in a COVID-19 World
por: Hildreth, C., et al.
Publicado: (2021)

Cross-World Covert Channel on ARM Trustzone through PMU
por: Li, Xinyao, et al.
Publicado: (2022)

Interactive or tailored digital interventions to increase uptake in cervical, breast, and colorectal cancer screening to reduce health inequity: a systematic review
por: Richardson-Parry, Afua, et al.
Publicado: (2023)

A real‐world study of alemtuzumab in a cohort of Italian patients
por: Russo, Cinzia Valeria, et al.
Publicado: (2021)

Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials
por: Harris, Sarah, et al.
Publicado: (2021)

PRS32 Management Of The Covid-19 Pandemic Around Public Health: Ethical Perspectives
por: Alcayaga, C., et al.
Publicado: (2021)

Central nervous system atrophy predicts future dynamics of disability progression in a real‐world multiple sclerosis cohort
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)
por: Butzkueven, Helmut, et al.
Publicado: (2020)

A real‐world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described ‘spasticity‐plus syndrome’
por: Patti, Francesco, et al.
Publicado: (2022)

Imported Fevers: CME Lecture
por: Ellis, C J
Publicado: (1995)

Post-graduate CME
por: Andrade, Chittaranjan
Publicado: (2008)

Anxiety is more important than depression in MS – Commentary
por: de Jong, Brigit A, et al.
Publicado: (2018)

PMU29 Burden of COVID-19 Consequences: an Example of Post-viral Chronic Fatigue Syndrome
por: Araja, D., et al.
Publicado: (2021)

Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes
por: De Stefano, Nicola, et al.
Publicado: (2014)

Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions
por: Muhlert, Nils, et al.
Publicado: (2014)

Tobacco smoking and excess mortality in multiple sclerosis: a cohort study
por: Manouchehrinia, Ali, et al.
Publicado: (2014)

Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial
por: Olsson, Tomas, et al.
Publicado: (2014)

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT
por: Edan, G, et al.
Publicado: (2014)

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
por: Butzkueven, Helmut, et al.
Publicado: (2014)

Changes to anti-JCV antibody levels in a Swedish national MS cohort
por: Warnke, Clemens, et al.
Publicado: (2013)

Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research Database
por: Mackenzie, I S, et al.
Publicado: (2014)

Re-evaluating the treatment of acute optic neuritis
por: Bennett, Jeffrey L, et al.
Publicado: (2015)

The grey matter correlates of impaired decision-making in multiple sclerosis
por: Muhlert, Nils, et al.
Publicado: (2015)

MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis
por: Matthews, Lucy, et al.
Publicado: (2015)

Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
por: De Stefano, Nicola, et al.
Publicado: (2016)

A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway
por: Grytten, N, et al.
Publicado: (2016)

Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
por: Haider, Lukas, et al.
Publicado: (2014)

Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j9817836gdij9n7abkbluoi6q2